Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minggui Pan

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Diseases (Basel, Switzerland)|March 26, 2025
Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma CenterTed Kim, Clara Hao, Minggui Pan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 30, 2013
Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysisWei Tian, Wenping Ding, Sungkyoung Kim, et al.
The Permanente Journal|February 26, 2021
Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case ReportAndrew S Fang, Lee Jae Morse, Rosanna Wustrack, et al.
Cancers|April 30, 2021
Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone SarcomaMinggui Pan, Maily K Trieu, Manpreet Sidhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2024
Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced SarcomaAlex Q Lee, Clara Hao, Minggui Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulationMinggui Pan, Monte M Winslow, Lei Chen, et al.
Drug Design, Development and Therapy|October 22, 2015
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivoLian Zhang, Sungkyoung Kim, Wenping Ding, et al.
Medical Sciences (Basel, Switzerland)|December 14, 2017
Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung AdenocarcinomaMichelle Levy, Liisa Lyon, Erika Barbero, et al.
International Journal of Molecular Sciences|June 10, 2023
Treatment of De-Differentiated Liposarcoma in the Era of ImmunotherapyMaggie Y Zhou, Nam Q Bui, Gregory W Charville, et al.
Journal of Oncology Practice|April 3, 2019
Germline <i>BRCA1</i> Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to RucaparibTiffany Seto, Deepti Pujare, Mee-Na Song, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Diseases (Basel, Switzerland)|March 26, 2025
Gemcitabine Plus Docetaxel, Dacarbazine, Doxorubicin Combinations, or Doxorubicin Alone as First-Line Treatment for Advanced/Metastatic Leiomyosarcoma: A Retrospective Analysis at a Sarcoma CenterTed Kim, Clara Hao, Minggui Pan, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 30, 2013
Efficacy and safety profile of combining agents against epidermal growth factor receptor or vascular endothelium growth factor receptor with gemcitabine-based chemotherapy in patients with advanced pancreatic cancer: a meta-analysisWei Tian, Wenping Ding, Sungkyoung Kim, et al.
The Permanente Journal|February 26, 2021
Complete Regression of Rhabdomyosarcoma in an Adult Secondary to Postoperative Wound Infection Following Limb Salvage Surgery: A Case ReportAndrew S Fang, Lee Jae Morse, Rosanna Wustrack, et al.
Cancers|April 30, 2021
Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone SarcomaMinggui Pan, Maily K Trieu, Manpreet Sidhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2024
Histologic and Immunologic Factors Associated with Response to Immune Checkpoint Inhibitors in Advanced SarcomaAlex Q Lee, Clara Hao, Minggui Pan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Enhanced NFATc1 nuclear occupancy causes T cell activation independent of CD28 costimulationMinggui Pan, Monte M Winslow, Lei Chen, et al.
Drug Design, Development and Therapy|October 22, 2015
Arsenic sulfide inhibits cell migration and invasion of gastric cancer in vitro and in vivoLian Zhang, Sungkyoung Kim, Wenping Ding, et al.
Medical Sciences (Basel, Switzerland)|December 14, 2017
Histologic Grade Is Predictive of Incidence of Epidermal Growth Factor Receptor Mutations in Metastatic Lung AdenocarcinomaMichelle Levy, Liisa Lyon, Erika Barbero, et al.
International Journal of Molecular Sciences|June 10, 2023
Treatment of De-Differentiated Liposarcoma in the Era of ImmunotherapyMaggie Y Zhou, Nam Q Bui, Gregory W Charville, et al.
Journal of Oncology Practice|April 3, 2019
Germline <i>BRCA1</i> Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to RucaparibTiffany Seto, Deepti Pujare, Mee-Na Song, et al.
Pageof 5